MAPT and Alzheimer disease: From a pathological perspective, AD is defined by the presence of plaques of amyloid-beta (Aβ) peptides (derived from the proteolytic cleavage of the amyloid precursor protein) and neurofibrillary tangles (produced by hyperphosphorylated tau protein forms) [3].